Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Dark

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The British Journal of Clinical Psychology|June 10, 2020
Randomized controlled trial of social cognition and interaction training compared to befriending groupFrances Dark, James G Scott, Andrea Baker, et al.
The Medical Journal of Australia|September 19, 2017
The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disordersDavid J Castle, Cherrie A Galletly, Frances Dark, et al.
Australasian Journal on Ageing|December 29, 2025
Translation, Cultural Adaptation and Validation of the British Sign Language Cognitive Screening Tool Into Australian Sign LanguageFrances Dark, Gabrielle Ritchie, Rebecca Reedman, et al.
The Australian and New Zealand Journal of Psychiatry|January 16, 2026
<i>Australian and New Zealand Journal of Psychiatry</i> Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophreniaShuichi Suetani, Frances Dark, Susanna Every-Palmer, et al.
The Australian and New Zealand Journal of Psychiatry|November 11, 2025
The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trialNicole Korman, Robert Stanton, Mike Trott, et al.
Trials|April 9, 2017
The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trialAlex Ryan, Andrea Baker, Frances Dark, et al.
BMC Psychiatry|September 16, 2016
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptomsSusan L Rossell, Paul S Francis, Cherrie Galletly, et al.
Schizophrenia Bulletin|July 20, 2022
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative SymptomsErica Neill, Susan L Rossell, Caitlin Yolland, et al.
Trials|April 10, 2019
Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosisCarmen Lim, Andrea Baker, Sukanta Saha, et al.
The Australian and New Zealand Journal of Psychiatry|April 26, 2026
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendationsNicola Warren, Cullen O'Gorman, Frances Dark, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The British Journal of Clinical Psychology|June 10, 2020
Randomized controlled trial of social cognition and interaction training compared to befriending groupFrances Dark, James G Scott, Andrea Baker, et al.
The Medical Journal of Australia|September 19, 2017
The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disordersDavid J Castle, Cherrie A Galletly, Frances Dark, et al.
Australasian Journal on Ageing|December 29, 2025
Translation, Cultural Adaptation and Validation of the British Sign Language Cognitive Screening Tool Into Australian Sign LanguageFrances Dark, Gabrielle Ritchie, Rebecca Reedman, et al.
The Australian and New Zealand Journal of Psychiatry|January 16, 2026
<i>Australian and New Zealand Journal of Psychiatry</i> Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophreniaShuichi Suetani, Frances Dark, Susanna Every-Palmer, et al.
The Australian and New Zealand Journal of Psychiatry|November 11, 2025
The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trialNicole Korman, Robert Stanton, Mike Trott, et al.
Trials|April 9, 2017
The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trialAlex Ryan, Andrea Baker, Frances Dark, et al.
BMC Psychiatry|September 16, 2016
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptomsSusan L Rossell, Paul S Francis, Cherrie Galletly, et al.
Schizophrenia Bulletin|July 20, 2022
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative SymptomsErica Neill, Susan L Rossell, Caitlin Yolland, et al.
Trials|April 10, 2019
Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosisCarmen Lim, Andrea Baker, Sukanta Saha, et al.
The Australian and New Zealand Journal of Psychiatry|April 26, 2026
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendationsNicola Warren, Cullen O'Gorman, Frances Dark, et al.
Pageof 8